INmune Bio Inc. Announces USPTO Allowance of Key Patent Covering Its DN-TNFa Platform Technology for Treating Cancer Yahoo Finance
INmune Bio, Inc. (INMB), a clinical-stage immunology company focused on developing treatments that reprogram the patient’s innate immune system to fight …